Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

CX Therapeutics Inc
Profile last edited on: 8/10/2021      CAGE: 8AU26      UEI: X4QMS4CCBLL5

Business Identifier: Device to reduce pre-term births
Year Founded
2019
First Award
2020
Latest Award
2020
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

C/O M2D2 600 Suffolk Street Suite 250
Lowell, MA 01854
   (617) 306-6621
   info@cx-therapeutics.com
   www.cx-therapeutics.com
Location: Single
Congr. District: 03
County: Middlesex

Public Profile

Previously located in Lexington MA and now relocated in Lowell MA, Cx Therapeutics has developed a novel device designed to reduce preterm birth and improve outcomes for pregnant women with cervical insufficiency. Structured around development of an improved cerclage - the latter being erclage is a longstanding treatment for cervical insufficiency - the firm's principals are working with mechanical engineers and medical device experts to make cerclage safer and more effective

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$312,578
Phase II Dollars
$0
Total Awarded
$312,578

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2020 1 NIH $312,578
Project Title: A Novel Device for Cervical Insufficiency in Pregnant Women

Key People / Management

  Michael House -- Founder and President

  Sabrina Craigo

Company News

There are no news available.